Evidence map›Paper›PMID 25873305›Full record

ArticleASN neuro

Divergence in endothelin-1- and bradykinin-activated store-operated calcium entry in afferent sensory neurons.

Kalina Szteyn, Ruben Gomez, Kelly A Berg, Nathaniel A Jeske

Open access · goldAbstract read
In one paragraph

Article in ASN neuro. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Spinal TRPC3 promotes neuropathic pain and coordinates phospholipase C-induced mechanical hypersensitivity.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  6. PGE2 Potentiates Orai1-Mediated Calcium Entry Contributing to Peripheral Sensitization.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2024
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Bradykinin-mediated CaJournal of cellular and molecular medicine · 2018
    Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Kalina SzteynDepartment of Oral and Maxillofacial Surgery, University of Texas Health Science Center at San Antonio, TX, USA.
Ruben GomezDepartment of Oral and Maxillofacial Surgery, University of Texas Health Science Center at San Antonio, TX, USA.
Kelly A BergDepartment of Pharmacology, University of Texas Health Science Center at San Antonio, TX, USA.
Nathaniel A JeskeDepartment of Oral and Maxillofacial Surgery, University of Texas Health Science Center at San Antonio, TX, USA Department of Pharmacology, University of Texas Health Science Center at San Antonio, TX, USA Department of Physiology, University of Texas Health Science Center at San Antonio, TX, USA jeske@uthscsa.edu.
The University of Texas Health Science Center at San Antonio · US

Funding

Scaffolding the Transition to Chronic PainR01NS082746 · NINDS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI JESKE, NATHANIEL AARON · 2013 to 2017
$1.7M
NINDS NIH HHS NS082746NINDS NIH HHS R01 NS082746
6 · The paper itself

Abstract

Endothelin-1 (ET-1) and bradykinin (BK) are endogenous peptides that signal through Gαq/11-protein coupled receptors (GPCRs) to produce nociceptor sensitization and pain. Both peptides activate phospholipase C to stimulate Ca(2+) accumulation, diacylglycerol production, and protein kinase C activation and are rapidly desensitized via a G-protein receptor kinase 2-dependent mechanism. However, ET-1 produces a greater response and longer lasting nocifensive behavior than BK in multiple models, indicating a potentially divergent signaling mechanism in primary afferent sensory neurons. Using cultured sensory neurons, we demonstrate significant differences in both Ca(2+) influx and Ca(2+) release from intracellular stores following ET-1 and BK treatments. As intracellular store depletion may contribute to the regulation of other signaling cascades downstream of GPCRs, we concentrated our investigation on store-operated Ca(2+) channels. Using pharmacological approaches, we identified transient receptor potential canonical channel 3 (TRPC3) as a dominant contributor to Ca(2+) influx subsequent to ET-1 treatment. On the other hand, BK treatment stimulated Orai1 activation, with only minor input from TRPC3. Taken together, data presented here suggest that ET-1 signaling targets TRPC3, generating a prolonged Ca(2+) signal that perpetuates nocifensive responses. In contrast, Orai1 dominates as the downstream target of BK receptor activation and results in transient intracellular Ca(2+) increases and abridged nocifensive responses.

Indexed as

AnimalsBradykininCalciumCalcium ChannelsCells, CulturedEndothelin-1FootMaleNociceptive PainORAI1 ProteinRats, Sprague-DawleySensory Receptor CellsTrigeminal GanglionTRPC Cation ChannelsType C PhospholipasesBradykininCalciumCalcium ChannelsEndothelin-1ORAI1 ProteinOrai1 protein, ratTRPC3 cation channelTRPC Cation ChannelsType C PhospholipasesbradykininendothelininflammationpainSOCEtrigeminal neurons

Identifiers

PMID25873305
PMCPMC4397213
OpenAlexW2059886244

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.